INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2008

Bariatric surgery produces durable weight loss, high rates of type 2 diabetes remission, and reduced mortality with low 90-day operative mortality.

This review evaluates the safety and efficacy of bariatric surgery, focusing on adjustable gastric banding, gastric bypass, and biliopancreatic bypass with duodenal switch in individuals with severe obesity. Controlled randomized studies demonstrate durable weight loss exceeding 100 lb (46 kg), full and long-term remission of type 2 diabetes in over 80%, beneficial effects on other comorbidities, and significant reductions in all-cause mortality. In U.S. Centers of Excellence, the 90-day surgical mortality rate is 0.35%, comparable to complication rates seen after cholecystectomy.

Study type
Review
Who was studied
Individuals with severe obesity (body mass index >35 kg/m2)
What was measured
Weight loss, remission of comorbidities, all-cause mortality, and surgical complications/safety

THE PAPER

Bariatric surgery: risks and rewards.

Pories WJ. J Clin Endocrinol Metab, 2008.

PubMed 18987275 ↗DOI 10.1210/jc.2008-1641 ↗

Heart & arteriesDiabetes & blood sugarBlood pressureWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.